The Relevance of a Significant Correlation between ET-1 and Clinical Markers Such as Microalbuminuria and Fundus Oculi Changes in Early Detection of Diabetic Nephropathy in Type 2 Diabetes

Benereta Hoxha; Ilir Arapi

Authors

Benereta Hoxha
Ilir Arapi

Keywords:

biomarkers, endothelin-1, microalbuminuria, fundus oculi, diabetes, diabetic nephropathy

Abstract

Abstract not found

Downloads

How to Cite

The Relevance of a Significant Correlation between ET-1 and Clinical Markers Such as Microalbuminuria and Fundus Oculi Changes in Early Detection of Diabetic Nephropathy in Type 2 Diabetes. (2014). Global Journal of Medical Research, 14(F2), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/631

Download Citation

References

Eberhard Ritz, Ivan Rychlík, Francesco Locatelli, Serge Halimi (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. 34(5), 795-808.

P Bahman, Tabaei, Abdul Mph, Al-Kassab, Md, Liza Phd, Ilag, Catherine Md, Zawacki, Rn, William Bsn, Herman, Mph Md, Cda Stehouwer, J Lambert, Ajm Donker, Vwm Van Hinsbergh (1997) Endothelial dysfunction and the pathogenesis of diabetic angiopathy. 24.

Cda Stehouwer, J Yudkin, P Fioretto, R Nosadini (1998) How heterogeneous is microalbuminuria? The case for 'benign' and 'malignant' microalbuminuria. 13, 2751-2754.

(2012) Subject Index. 243-255.

M Brownlee (2005) The pathobiology of diabetic complications: a unifying mechanism. 54, 1615-1625.

Sarah Yuan, Robert Rigor (2010) University of California Davis.

Konstantin Birukov (2009) Small GTPases in mechanosensitive regulation of endothelial barrier. 77(1), 46-52.

D Versari, E Daghini, A Virdis, L Ghiadoni, S Taddei (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. 32, 314-321.

Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura, Yoko Tomobe, Mieko Kobayashi, Youji Mitsui, Yoshio Yazaki, Katsutoshi Goto, Tomoh Masaki (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. 332(6163), 411-415.

H Ito, Y Hirata, S Adachi, M Tanaka, M Tsujino, A Koike, A Nogami, F Murumo, M Hiroe (1993) Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.. 92(1), 398-403.

(1985) Diabetes Mellitus: Report of a WHO Study Group. 727(6).

M The, Association (2002) Unknown Title.

C Stehouwer (2004) Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. 19(4), 778-781.

B Becker, D Chappell, D Bruegger, T Annecke, M Jacob (2010) Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. 87(2), 300-310.

M Potenza, S Gagliardi, C Nacci, ' Carratu, Mr, M Montagnani (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. 16, 94-112.

S Belmadani, Y Park, Z Tang, A Feldman, W Chilian, C Zhang (2001) Effects of ET(A)-and ET(B)-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits. 27(6), 245-248.

Rg, A Madden, J Oliver, Tv ; Lewis, Maria Nabinger, Jacques, H Silvaluís, Canani (2008) Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus Claudete M. ZanattaFernando, GerchmanLucas Burttet Gustavo. 80(2), 299-304.

Bg1 Seligman, A Biolo, C Polanczyk, J Gross, N ; Clausell, M Simonson, W Herman (1993) Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1: cross-talk between G protein-coupled receptors and pp60csrc. 23(9), 9347-9357.

R Caldwell, M Bartoli, M Behzadian, A El-Remessy, M Al-Shabrawey, D Platt (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophys-iological mechanisms and treatment perspectives. 19, 442-455.

R Lucas, S Magez, De Leys, R Fransen, L Scheerlinck, J Rampelberg, M (2010) Vascular dysfunction in retinopathy-an emerging role for arginase. 81, 303-309.